Register to receive a free Europe Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials report synopsis and brochure
The full report suite on the European market for dental bone graft substitutes and other biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes.
Despite the fact that autograft procedures are becoming less popular, they still account for a considerably large portion of dental bone grafting procedures across Europe. As a result, the dental biomaterial market is significantly underdeveloped in Europe, relative to the U.S. market. A prevailing preference for xenograft materials characterizes the dental bone graft substitute market in Europe and very few regions have demonstrated a shift towards allograft materials. It is expected that stringent regulations and protocols set in place by the European Tissue and Cells Directive (EUTCD) will continue to limit the allograft market and overall dental biomaterial market in the future.
In recent years, the European dental biomaterial market has demonstrated improvements in growth due to several factors and trends. A major contributor of growth has been the healthy growth of the European dental implant market, particularly in regions where implant penetration is relatively low, such as France and the United Kingdom. Increased consumer awareness and marketing initiatives have driven the number of implant procedures that use dental bone graft substitutes to increase to over 40% in certain regions, with the utilization rate of dental barrier membranes growing proportionately. Finally, a growing number of dental implant companies have recently entered the biomaterial space in order to provide a total solution to their customer base. This influx of competitors has positively affected the overall market, due to increased customer exposure and ability to offer bundled product packages that include dental implants and biomaterials.
Other notable developments in the European dental biomaterial market include strategic partnerships between implant companies and biomaterial companies, increasing penetration of allograft materials and the introduction of innovative products that use new materials and composites of existing products.
In 2016, Geistlich maintained its leading position in the European dental biomaterial market, owing to its dominant presence in the dental bone graft substitute and dental barrier membrane markets.
For Further Information
More on the dental bone graft substitute market in the U.S. can be found in a series of reports published by iData Research entitled the Europe Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials. The suite covers reports on the following markets: dental bone graft substitutes, dental growth factors and dental barrier membranes.
The iData report series on dental bone graft substitutes covers the U.S., Argentina, Brazil, Mexico, China, Australia, Japan, South Korea and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about dental implant market data, register online or email us at [email protected] for a Europe Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials brochure and synopsis.